Free Trial
NASDAQ:ZYBT

Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Zhengye Biotechnology logo
$13.48 +3.05 (+29.24%)
As of 05/2/2025 04:00 PM Eastern

About Zhengye Biotechnology Stock (NASDAQ:ZYBT)

Key Stats

Today's Range
$10.18
$13.68
50-Day Range
$3.64
$14.15
52-Week Range
$3.50
$14.30
Volume
260,486 shs
Average Volume
294,787 shs
Market Capitalization
$635.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Receive ZYBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zhengye Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

ZYBT Stock News Headlines

Zhengye Biotechnology Holding Ltd.
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Zhengye Biotechnology Holding Limited (ZYBT)
See More Headlines

ZYBT Stock Analysis - Frequently Asked Questions

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of the year. Since then, ZYBT shares have increased by 177.4% and is now trading at $13.48.
View the best growth stocks for 2025 here
.

Zhengye Biotechnology (ZYBT) raised $6 million in an IPO on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners acted as the underwriter for the IPO.

Zhengye Biotechnology's lock-up period expires on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the expiration of Zhengye Biotechnology's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZYBT
Previous Symbol
NASDAQ:ZYBT
Fax
N/A
Employees
278
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$189.75 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$635.80 million
Optionable
N/A
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ZYBT) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners